{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:38:57Z","timestamp":1783708737861,"version":"3.55.0"},"reference-count":28,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":339,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aust Dent J"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1111\/adj.12217","type":"journal-article","created":{"date-parts":[[2014,8,16]],"date-time":"2014-08-16T06:53:49Z","timestamp":1408172029000},"page":"516-519","source":"Crossref","is-referenced-by-count":49,"title":["Denosumab and osteonecrosis of the jaws - the pharmacology, pathogenesis and a report of two cases"],"prefix":"10.1111","volume":"59","author":[{"given":"M","family":"O'Halloran","sequence":"first","affiliation":[{"name":"Department of Oral Surgery; School of Dentistry; The University of Western Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NM","family":"Boyd","sequence":"additional","affiliation":[{"name":"Department of Oral Pathology; School of Dentistry; The University of Western Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Smith","sequence":"additional","affiliation":[{"name":"Oral and Maxillofacial Surgery Private Practice; Perth Western Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,9,27]]},"reference":[{"key":"10.1111\/adj.12217-BIB0001|adj12217-cit-0001","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10147-013-0561-6","article-title":"Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials","volume":"19","author":"Qi","year":"2014","journal-title":"Int J Clin Oncol"},{"key":"10.1111\/adj.12217-BIB0002|adj12217-cit-0002","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jbspin.2012.08.005","article-title":"Bisphosphonates and glucocorticoid-induced osteoporosis: efficacy and tolerability","volume":"80","author":"Lespessailles","year":"2013","journal-title":"Joint Bone Spine"},{"key":"10.1111\/adj.12217-BIB0003|adj12217-cit-0003","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.oraloncology.2013.06.008","article-title":"Osteonecrosis of the jaw - Prevention and treatment strategies for oral health professionals","volume":"49","author":"Hinchy","year":"2013","journal-title":"Oral Oncol"},{"issue":"5 Suppl","key":"10.1111\/adj.12217-BIB0004|adj12217-cit-0004","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.joms.2008.12.004","article-title":"Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws","volume":"67","author":"Dodson","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1111\/adj.12217-BIB0005|adj12217-cit-0005","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.oraloncology.2012.03.028","article-title":"Bisphosphonate-related osteonecrosis of the jaws-a review","volume":"48","author":"K\u00fchl","year":"2012","journal-title":"Oral Oncol"},{"issue":"5 Suppl","key":"10.1111\/adj.12217-BIB0006|adj12217-cit-0006","first-page":"2","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 update","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1111\/adj.12217-BIB0007|adj12217-cit-0007","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.joms.2009.10.010","article-title":"Osteonecrosis of the jaw in a patient on Denosumab","volume":"68","author":"Aghaloo","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1111\/adj.12217-BIB0008|adj12217-cit-0008","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bjoms.2009.08.030","article-title":"Osteonecrosis of the jaws induced by anti-RANK ligand therapy","volume":"48","author":"Taylor","year":"2010","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1111\/adj.12217-BIB0009|adj12217-cit-0009","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.mayocp.2013.01.002","article-title":"Osteonecrosis of the jaw after osteoporosis therapy with denosumab following long-term bisphosphonate therapy","volume":"88","author":"Rachner","year":"2013","journal-title":"Mayo Clin Proc"},{"issue":"672-676","key":"10.1111\/adj.12217-BIB0010|adj12217-cit-0010","first-page":"678","article-title":"A current update on osteonecrosis of the jaw and bisphosphonates","volume":"38","author":"Arrain","year":"2011","journal-title":"Dent Update"},{"key":"10.1111\/adj.12217-BIB0011|adj12217-cit-0011","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.joms.2012.07.049","article-title":"Osteonecrosis of the jaw onset times are based on the route of bisphosphonate therapy","volume":"71","author":"Fleisher","year":"2013","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1111\/adj.12217-BIB0012|adj12217-cit-0012","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.oooo.2012.08.439","article-title":"The relationship of denosumab pharmacology and osteonecrosis of the jaws","volume":"114","author":"Malan","year":"2012","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1111\/adj.12217-BIB0013|adj12217-cit-0013","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00198-010-1177-6","article-title":"Denosumab-related osteonecrosis of the jaws","volume":"22","author":"Kyrgidis","year":"2011","journal-title":"Osteoporos Int"},{"issue":"3 Suppl","key":"10.1111\/adj.12217-BIB0014|adj12217-cit-0014","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1532-3382(12)70046-5","article-title":"Antiresorptives and osteonecrosis of the jaw","volume":"12","author":"Yamashita","year":"2012","journal-title":"J Evid Based Dent Pract"},{"key":"10.1111\/adj.12217-BIB0015|adj12217-cit-0015","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1111\/adj.12217-BIB0016|adj12217-cit-0016","first-page":"1793","article-title":"Denosumab and anti-angiogenetic drug-related osteonecrosis of the jaw: an uncommon but potentially severe disease","volume":"33","author":"Sivolella","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1111\/adj.12217-BIB0017|adj12217-cit-0017","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrendo.2010.195","article-title":"Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review","volume":"7","author":"Migliorati","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"5 Suppl","key":"10.1111\/adj.12217-BIB0018|adj12217-cit-0018","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.joms.2009.01.003","article-title":"Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies","volume":"67","author":"Assael","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1111\/adj.12217-BIB0019|adj12217-cit-0019","doi-asserted-by":"crossref","first-page":"981","DOI":"10.14219\/jada.archive.2012.0323","article-title":"Denosumab-related osteonecrosis of the jaw","volume":"143","author":"Diz","year":"2012","journal-title":"J Am Dent Assoc"},{"key":"10.1111\/adj.12217-BIB0020|adj12217-cit-0020","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jcms.2013.05.038","article-title":"Successful surgical management of osteonecrosis of the jaw due to RANK-ligand inhibitor treatment using fluorescence guided bone resection","volume":"41","author":"Otto","year":"2013","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1111\/adj.12217-BIB0021|adj12217-cit-0021","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1111\/adj.12217-BIB0022|adj12217-cit-0022","doi-asserted-by":"crossref","first-page":"e437","DOI":"10.1016\/j.oooo.2012.01.046","article-title":"Review of current literature and implications of RANKL inhibitors for oral health care providers","volume":"116","author":"Epstein","year":"2013","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1111\/adj.12217-BIB0023|adj12217-cit-0023","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12020-011-9580-0","article-title":"Glucocorticoid-induced osteonecrosis","volume":"41","author":"Weinstein","year":"2012","journal-title":"Endocrine"},{"key":"10.1111\/adj.12217-BIB0024|adj12217-cit-0024","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1016\/j.ejca.2012.08.002","article-title":"Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials","volume":"48","author":"Lipton","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1111\/adj.12217-BIB0025|adj12217-cit-0025","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ecl.2012.04.004","article-title":"Glucocorticoid-induced osteoporosis and osteonecrosis","volume":"41","author":"Weinstein","year":"2012","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1111\/adj.12217-BIB0026|adj12217-cit-0026","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4103\/0973-1482.92020","article-title":"Osteonecrosis of jaw with the use of Denosumab","volume":"7","author":"Akhtar","year":"2011","journal-title":"J Cancer Res Ther"},{"key":"10.1111\/adj.12217-BIB0027|adj12217-cit-0027","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2147\/TCRM.S24239","article-title":"Long-term treatment of osteoporosis: safety and efficacy appraisal of Denosumab","volume":"8","author":"Anastasilakis","year":"2012","journal-title":"Ther Clin Risk Manag"},{"key":"10.1111\/adj.12217-BIB0028|adj12217-cit-0028","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.joms.2013.09.008","article-title":"Stage 0 Osteonecrosis of the jaw in a patient on Denosumab","volume":"72","author":"Aghaloo","year":"2014","journal-title":"J Oral Maxillofac Surg"}],"container-title":["Australian Dental Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fadj.12217","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/adj.12217\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T11:52:23Z","timestamp":1625313143000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/adj.12217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,27]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,12]]}},"URL":"https:\/\/doi.org\/10.1111\/adj.12217","relation":{},"ISSN":["0045-0421"],"issn-type":[{"value":"0045-0421","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9,27]]}}}